{"id":140426,"date":"2022-07-18T11:09:34","date_gmt":"2022-07-18T04:09:34","guid":{"rendered":"https:\/\/nawacita.co\/?p=140426"},"modified":"2022-07-18T11:09:35","modified_gmt":"2022-07-18T04:09:35","slug":"bpom-izinkan-paxlovid-untuk-pengobatan-covid-19","status":"publish","type":"post","link":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/","title":{"rendered":"BPOM Izinkan Paxlovid untuk Pengobatan COVID-19"},"content":{"rendered":"

BPOM Izinkan Paxlovid untuk Pengobatan COVID-19<\/h1>\n

Jakarta, Nawacita<\/a><\/strong> | BPOM izinkan penggunaan Paxlovid untuk pengobatan COVID-19 di Indonesia. Penerbitan izin itu dikeluarkan Minggu kemarin. Obat Paxlovid tablet salut selaput, obat terapi antivirus inhibitor protease SARS-CoV-2 yang dikembangkan dan diproduksi oleh Pfizer.<\/p>\n

Kepala BPOM Penny K Lukito menjelaskan Paxlovid dalam bentuk kombipak yang terdiri atas Nirmatrelvir 150 mg dan Ritonavir 100 mg dengan indikasi untuk mengobati COVID-19 pada orang dewasa yang tidak memerlukan oksigen tambahan dan yang berisiko tinggi terjadi progresivitas menuju COVID-19 berat.<\/p>\n

Anjuran penggunaannya, menurut BPOM, Nirmatrelvir 300 mg (dua tablet 150 mg) dan Ritonavir 100 mg (satu tablet 100 mg) diminum bersama-sama dua kali sehari selama lima hari.<\/p>\n

Baca Juga:\u00a0Disebut BPOM Berbahaya, Kopi Parasetamol Masih Dijual di E-Commerce<\/a><\/strong><\/p>\n

Menurut dia, efek samping penggunaan obat itu dalam kisaran ringan hingga sedang berupa dysgeusia atau gangguan indra perasa (5,6 persen), diare (3,1 persen), sakit kepala (1,4 persen), dan muntah (1,1 persen).<\/p>\n

Ia mengatakan bahwa hasil uji klinik fase 2 dan 3 menunjukkan Paxlovid dapat menurunkan risiko hospitalisasi atau kematian hingga 89 persen pada pasien COVID-19 dewasa dengan komorbid atau penyakit penyerta yang tidak dirawat di rumah sakit.<\/p>\n

“Komorbid yang berkaitan dengan peningkatan risiko ini seperti lansia, obesitas, perokok aktif, riwayat penyakit jantung, diabetes, atau gangguan ginjal,” katanya dalam siara pers BPOM Senin hari ini.<\/p>\n

\"BPOM<\/a>
Obat Paxlovid<\/figcaption><\/figure>\n

Paxlovid menambah isi daftar jenis antivirus yang bisa digunakan dalam penanganan pasien COVID-19 di Indonesia. Selain Paxlovid, BPOM telah mengeluarkan izin penggunaan darurat obat antivirus Favipiravir dan Remdesivir (2020), antibodi monoklonal Regdanvimab (2021), serta Molnupiravir (2022).<\/p>\n

BPOM bersama Kementerian Kesehatan mengawasi penggunaan Paxlovid dan obat-obat terapi COVID-19 yang sudah diizinkan penggunaannya di Indonesia.<\/p>\n

Penny mengatakan, BPOM melakukan pengawasan dari hulu hingga hilir untuk mencegah peredaran obat secara ilegal. Pengawasan dilakukan mulai dari pemasukan bahan baku obat, produksi obat, distribusi obat, hingga produk obat beredar di pasaran.<\/p>\n

“Kami mengimbau masyarakat untuk lebih waspada sebelum membeli atau mengonsumsi produk obat. Masyarakat harus menjadi konsumen cerdas, hindari mengonsumsi obat-obat ilegal,” demikian Penny K Lukito. antr<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

BPOM Izinkan Paxlovid untuk Pengobatan COVID-19 Jakarta, Nawacita | BPOM izinkan penggunaan Paxlovid untuk pengobatan COVID-19 di Indonesia. Penerbitan izin itu dikeluarkan Minggu kemarin. Obat Paxlovid tablet salut selaput, obat terapi antivirus inhibitor protease SARS-CoV-2 yang dikembangkan dan diproduksi oleh Pfizer. Kepala BPOM Penny K Lukito menjelaskan Paxlovid dalam bentuk kombipak yang terdiri atas Nirmatrelvir […]<\/p>\n","protected":false},"author":1459,"featured_media":140429,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[15857,28669,40561,43993],"class_list":{"0":"post-140426","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nasional","8":"tag-bpom","9":"tag-covid-19","10":"tag-paxlovid","11":"tag-paxlovid-untuk-pengobatan-covid-19"},"yoast_head":"\nBPOM Izinkan Paxlovid untuk Pengobatan COVID-19 - Nawacita<\/title>\n<meta name=\"description\" content=\"Jakarta, Nawacita | BPOM izinkan penggunaan Paxlovid untuk pengobatan COVID-19 di Indonesia. Penerbitan izin itu dikeluarkan Minggu kemarin.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BPOM Izinkan Paxlovid untuk Pengobatan COVID-19 - Nawacita\" \/>\n<meta property=\"og:description\" content=\"Jakarta, Nawacita | BPOM izinkan penggunaan Paxlovid untuk pengobatan COVID-19 di Indonesia. Penerbitan izin itu dikeluarkan Minggu kemarin.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Nawacita\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/nawacitaco-1763136813898723\/?ref=aymt_homepage_panel\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-18T04:09:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-18T04:09:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/07\/1200x768_has-recommande-remboursement-anti-viral-pfizer-paxlovid.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Nuris Mardhatika\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@nawacit4\" \/>\n<meta name=\"twitter:site\" content=\"@nawacit4\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nuris Mardhatika\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/07\\\/18\\\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/07\\\/18\\\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\\\/\"},\"author\":{\"name\":\"Nuris Mardhatika\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#\\\/schema\\\/person\\\/140e3531b7814b46fa8c6e0b288251b8\"},\"headline\":\"BPOM Izinkan Paxlovid untuk Pengobatan COVID-19\",\"datePublished\":\"2022-07-18T04:09:34+00:00\",\"dateModified\":\"2022-07-18T04:09:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/07\\\/18\\\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\\\/\"},\"wordCount\":325,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/07\\\/18\\\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/1200x768_has-recommande-remboursement-anti-viral-pfizer-paxlovid.webp\",\"keywords\":[\"BPOM\",\"COVID-19\",\"paxlovid\",\"Paxlovid untuk pengobatan COVID-19\"],\"articleSection\":[\"Nasional\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/07\\\/18\\\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/07\\\/18\\\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\\\/\",\"url\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/07\\\/18\\\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\\\/\",\"name\":\"BPOM Izinkan Paxlovid untuk Pengobatan COVID-19 - Nawacita\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/07\\\/18\\\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/07\\\/18\\\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/1200x768_has-recommande-remboursement-anti-viral-pfizer-paxlovid.webp\",\"datePublished\":\"2022-07-18T04:09:34+00:00\",\"dateModified\":\"2022-07-18T04:09:35+00:00\",\"description\":\"Jakarta, Nawacita | BPOM izinkan penggunaan Paxlovid untuk pengobatan COVID-19 di Indonesia. Penerbitan izin itu dikeluarkan Minggu kemarin.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/07\\\/18\\\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/07\\\/18\\\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/07\\\/18\\\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/1200x768_has-recommande-remboursement-anti-viral-pfizer-paxlovid.webp\",\"contentUrl\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/1200x768_has-recommande-remboursement-anti-viral-pfizer-paxlovid.webp\",\"width\":1200,\"height\":768,\"caption\":\"BPOM Izinkan Paxlovid untuk Pengobatan COVID-19\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/07\\\/18\\\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nawacita.co\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BPOM Izinkan Paxlovid untuk Pengobatan COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#website\",\"url\":\"https:\\\/\\\/nawacita.co\\\/\",\"name\":\"Nawacita\",\"description\":\"Berita Kementerian, BUMN, Pemerintah dan Politik\",\"publisher\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nawacita.co\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#organization\",\"name\":\"Nawacita\",\"url\":\"https:\\\/\\\/nawacita.co\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Logo-Nawacita-2021.png\",\"contentUrl\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Logo-Nawacita-2021.png\",\"width\":1676,\"height\":422,\"caption\":\"Nawacita\"},\"image\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/nawacitaco-1763136813898723\\\/?ref=aymt_homepage_panel\",\"https:\\\/\\\/x.com\\\/nawacit4\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#\\\/schema\\\/person\\\/140e3531b7814b46fa8c6e0b288251b8\",\"name\":\"Nuris Mardhatika\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/59991d6a6a57ee9bed1ddf63211978943632845fd878baa6ed3380e9f50a0c06?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/59991d6a6a57ee9bed1ddf63211978943632845fd878baa6ed3380e9f50a0c06?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/59991d6a6a57ee9bed1ddf63211978943632845fd878baa6ed3380e9f50a0c06?s=96&d=mm&r=g\",\"caption\":\"Nuris Mardhatika\"},\"sameAs\":[\"https:\\\/\\\/nawacita.co\"],\"url\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/author\\\/nurismardhatika\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BPOM Izinkan Paxlovid untuk Pengobatan COVID-19 - Nawacita","description":"Jakarta, Nawacita | BPOM izinkan penggunaan Paxlovid untuk pengobatan COVID-19 di Indonesia. Penerbitan izin itu dikeluarkan Minggu kemarin.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/","og_locale":"en_US","og_type":"article","og_title":"BPOM Izinkan Paxlovid untuk Pengobatan COVID-19 - Nawacita","og_description":"Jakarta, Nawacita | BPOM izinkan penggunaan Paxlovid untuk pengobatan COVID-19 di Indonesia. Penerbitan izin itu dikeluarkan Minggu kemarin.","og_url":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/","og_site_name":"Nawacita","article_publisher":"https:\/\/www.facebook.com\/nawacitaco-1763136813898723\/?ref=aymt_homepage_panel","article_published_time":"2022-07-18T04:09:34+00:00","article_modified_time":"2022-07-18T04:09:35+00:00","og_image":[{"width":1200,"height":768,"url":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/07\/1200x768_has-recommande-remboursement-anti-viral-pfizer-paxlovid.webp","type":"image\/webp"}],"author":"Nuris Mardhatika","twitter_card":"summary_large_image","twitter_creator":"@nawacit4","twitter_site":"@nawacit4","twitter_misc":{"Written by":"Nuris Mardhatika","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/#article","isPartOf":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/"},"author":{"name":"Nuris Mardhatika","@id":"https:\/\/nawacita.co\/#\/schema\/person\/140e3531b7814b46fa8c6e0b288251b8"},"headline":"BPOM Izinkan Paxlovid untuk Pengobatan COVID-19","datePublished":"2022-07-18T04:09:34+00:00","dateModified":"2022-07-18T04:09:35+00:00","mainEntityOfPage":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/"},"wordCount":325,"commentCount":0,"publisher":{"@id":"https:\/\/nawacita.co\/#organization"},"image":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/07\/1200x768_has-recommande-remboursement-anti-viral-pfizer-paxlovid.webp","keywords":["BPOM","COVID-19","paxlovid","Paxlovid untuk pengobatan COVID-19"],"articleSection":["Nasional"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/","url":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/","name":"BPOM Izinkan Paxlovid untuk Pengobatan COVID-19 - Nawacita","isPartOf":{"@id":"https:\/\/nawacita.co\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/07\/1200x768_has-recommande-remboursement-anti-viral-pfizer-paxlovid.webp","datePublished":"2022-07-18T04:09:34+00:00","dateModified":"2022-07-18T04:09:35+00:00","description":"Jakarta, Nawacita | BPOM izinkan penggunaan Paxlovid untuk pengobatan COVID-19 di Indonesia. Penerbitan izin itu dikeluarkan Minggu kemarin.","breadcrumb":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/#primaryimage","url":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/07\/1200x768_has-recommande-remboursement-anti-viral-pfizer-paxlovid.webp","contentUrl":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/07\/1200x768_has-recommande-remboursement-anti-viral-pfizer-paxlovid.webp","width":1200,"height":768,"caption":"BPOM Izinkan Paxlovid untuk Pengobatan COVID-19"},{"@type":"BreadcrumbList","@id":"https:\/\/nawacita.co\/index.php\/2022\/07\/18\/bpom-izinkan-paxlovid-untuk-pengobatan-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nawacita.co\/"},{"@type":"ListItem","position":2,"name":"BPOM Izinkan Paxlovid untuk Pengobatan COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/nawacita.co\/#website","url":"https:\/\/nawacita.co\/","name":"Nawacita","description":"Berita Kementerian, BUMN, Pemerintah dan Politik","publisher":{"@id":"https:\/\/nawacita.co\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nawacita.co\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/nawacita.co\/#organization","name":"Nawacita","url":"https:\/\/nawacita.co\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nawacita.co\/#\/schema\/logo\/image\/","url":"https:\/\/nawacita.co\/wp-content\/uploads\/2021\/10\/Logo-Nawacita-2021.png","contentUrl":"https:\/\/nawacita.co\/wp-content\/uploads\/2021\/10\/Logo-Nawacita-2021.png","width":1676,"height":422,"caption":"Nawacita"},"image":{"@id":"https:\/\/nawacita.co\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/nawacitaco-1763136813898723\/?ref=aymt_homepage_panel","https:\/\/x.com\/nawacit4"]},{"@type":"Person","@id":"https:\/\/nawacita.co\/#\/schema\/person\/140e3531b7814b46fa8c6e0b288251b8","name":"Nuris Mardhatika","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/59991d6a6a57ee9bed1ddf63211978943632845fd878baa6ed3380e9f50a0c06?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/59991d6a6a57ee9bed1ddf63211978943632845fd878baa6ed3380e9f50a0c06?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/59991d6a6a57ee9bed1ddf63211978943632845fd878baa6ed3380e9f50a0c06?s=96&d=mm&r=g","caption":"Nuris Mardhatika"},"sameAs":["https:\/\/nawacita.co"],"url":"https:\/\/nawacita.co\/index.php\/author\/nurismardhatika\/"}]}},"jetpack_featured_media_url":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/07\/1200x768_has-recommande-remboursement-anti-viral-pfizer-paxlovid.webp","_links":{"self":[{"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/posts\/140426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/users\/1459"}],"replies":[{"embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/comments?post=140426"}],"version-history":[{"count":0,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/posts\/140426\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/media\/140429"}],"wp:attachment":[{"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/media?parent=140426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/categories?post=140426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/tags?post=140426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}